|Day's Range||84.48 - 85.32|
|52 Week Range||66.93 - 86.90|
|PE Ratio (TTM)||31.94|
|Dividend & Yield||2.72 (3.23%)|
|1y Target Est||N/A|
Rating Action: Moody's changes outlook on GSK's A2 rating to stable from negative; affirms ratings. Global Credit Research- 27 Jul 2017. London, 27 July 2017-- Moody's Investors Service has today changed ...
Ophthotech Corporation (OPHT) reported narrower-than-expected loss in the second quarter and also beat sales expectations.
Novartis AG (ADR) (NYSE: NVS ) has been all over the news lately as its cancer drug moves closer to FDA approval, and Morgan Stanley analyst Vincent Meunier believes the recent news flow suggests a less ...